Showing results (51-60 of 105) with videos related to
Sort By:
Pageof 11
Health Policy (Amsterdam, Netherlands)|May 1, 2024
Economic Evaluations of Obesity-Targeted Sugar-Sweetened Beverage (SSB) Taxes-A Review to Identify Methodological IssuesKittiphong Thiboonboon, Richard De Abreu Lourenco, Paula Cronin, et al.Patient Education and Counseling|May 12, 2015
Patient led goal setting in chronic low back pain-What goals are important to the patient and are they aligned to what we measure?Tania Gardner, Kathryn Refshauge, James McAuley, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 30, 2006
Implementation of Advanced Access in general practice: postal survey of practicesStephen Goodall, Alan Montgomery, Jon Banks, et al.Heart, Lung & Circulation|December 17, 2015
Cost-effectiveness of a Population-based Lifestyle Intervention to Promote Healthy Weight and Physical Activity in Non-attenders of Cardiac RehabilitationQinglu Cheng, Jody Church, Marion Haas, et al.Physiotherapy Theory and Practice|January 19, 2018
Goal setting practice in chronic low back pain. What is current practice and is it affected by beliefs and attitudes?Tania Gardner, Kathryn Refshauge, James McAuley, et al.Journal of Physiotherapy|June 29, 2017
Physiotherapists' beliefs and attitudes influence clinical practice in chronic low back pain: a systematic review of quantitative and qualitative studiesTania Gardner, Kathryn Refshauge, Lorraine Smith, et al.Applied Health Economics and Health Policy|May 27, 2026
Societal Preferences for Assessment Pathways of Rare Disease Drugs: A Discrete Choice ExperimentConstanza Vargas, Richard De Abreu Lourenco, Deborah J Street, et al.Orphanet Journal of Rare Diseases|December 30, 2025
Using a discrete choice experiments to explore societal preferences for valuing new drugs for rare diseasesConstanza Vargas, Stephen Goodall, Deborah J Street, et al.Pharmacoeconomics|May 22, 2016
Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast CancerBonny Parkinson, Rosalie Viney, Marion Haas, et al.International Journal of Technology Assessment in Health Care|June 20, 2013
Cost-effectiveness of an advance notification letter to increase colorectal cancer screeningPaula Cronin, Stephen Goodall, Trevor Lockett, et al.Pageof 11